CRSP - If You Invested $5000 in CRISPR Therapeutics in January This Is How Much You Would Have Today
2023-12-04 05:00:00 ET
CRISPR Therapeutics ' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech company is getting closer and closer to a major milestone: potential regulatory approval of what may become its first product. In just a few days, the U.S. Food and Drug Administration (FDA) will decide on exa-cel for sickle cell disease -- and in March, the agency will consider exa-cel for beta thalassemia.
Excitement about the upcoming decisions has breathed new life into the stock, which prior to this year had declined more than 60% from its peak back in 2021. So, if you decided to buy CRISPR Therapeutics right at the start of this year, you clearly have benefited. How much would you have today if you invested $5,000 on the first trading day of this year? Let's find out.
Image source: Getty Images.
For further details see:
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today